ACE and myocardial infarction: Clinical trials showed that the intake of anti-platelet agents [60–62], statins [63–65], ACE-inhibitors [66–68], and β-blockers [69–71] lower the risk of death after myocardial infarction, which could not be shown in our analyses as we had a mainly negative association of PDC rates and death.